ALLMedicine™ Meningococcal Meningitis Center

Feb 10th, 2021 - Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningo...

Nov 23rd, 2020 - Vaccines to prevent meningococcal meningitis in the African meningitis belt include PsACWY, a polysaccharide-only vaccine; and PsA-TT, a polysaccharide-protein conjugate vaccine. Protein-energy undernutrition, a condition where children do not rec...

Nov 18th, 2020 - Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported case of reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During the treatment of meni...

Nov 7th, 2020 - Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis...

Oct 2nd, 2020 - Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB ar...

Dec 6th, 2011 - Meningococcal meningitis is a rare but often fatal disease. Throughout adolescence, the incidence of meningococcal meningitis increases, reaching a peak among individuals between the ages of 16 and 21 years. Vaccines are available to combat this d...

Jul 1st, 2010 - Background: The prompt diagnosis of meningitis is essential for a good outcome. Aim: This study was designed to differentiate children with meningococcal meningitis, aseptic meningitis, and no meningitis. Patients and Methods: A total of 150 chi...

MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuad...

Feb 10th, 2021 - Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningo...

Nov 23rd, 2020 - Vaccines to prevent meningococcal meningitis in the African meningitis belt include PsACWY, a polysaccharide-only vaccine; and PsA-TT, a polysaccharide-protein conjugate vaccine. Protein-energy undernutrition, a condition where children do not rec...

Nov 18th, 2020 - Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported case of reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During the treatment of meni...

Nov 7th, 2020 - Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis...

Oct 2nd, 2020 - Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB ar...

Jul 7th, 2013 - Reasons for Not Vaccinating Adolescents: National Immunization Survey of Teens, 2008-2010 Darden PM, Thompson DM, Roberts JR, et al Pediatrics. 2013;131:645-651 Vaccinating Teens Healthy People 2020 goals for adolescent immunization rates are 90% ...

Jul 1st, 2010 - Background: The prompt diagnosis of meningitis is essential for a good outcome. Aim: This study was designed to differentiate children with meningococcal meningitis, aseptic meningitis, and no meningitis. Patients and Methods: A total of 150 chi...

MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuad...